Govvi supplement contains heart attack ingredient, FDA warns
The FDA has issued a December 21st advisory against Govvi’s WOW! supplement.
The federal regulator warns consuming WOW! can “lead to cardiovascular problems, including heart attack, shortness of breath and tightening of the chest.”
The culprit in WOW!, marketed as a weight loss supplement, is DMAA (1,3-dimethylamylamine, methylhexanamine or geranium extract).
Govvi doesn’t disclose DMAA as an ingredient in WOW!, making it an undeclared ingredient.
As a result of WOW! containing undeclared DMAA;
The Food and Drug Administration is advising consumers not to purchase or use Govvi WOW!, a product promoted and sold for weight loss on various websites, including eBay and possibly in some retail stores.
In an August 2018 advisory, marked current as of February 2023, the FDA writes;
DMAA (1,3-dimethylamylamine) is an amphetamine derivative that has been marketed in sports performance and weight loss products, many of which are sold as dietary supplements.
DMAA is not a dietary ingredient, and DMAA-containing products marketed as dietary supplements are illegal and their marketing violates the law.
It is unclear whether the FDA will take further action against Govvi. The issuing of a preliminary warning would certainly suggest so.
Govvi launched in mid 2022 and is fronted by CEO Lance Conrad.
Originally marketing only fuel tabs, the company has since branched out into nutritional supplements.